{"nct_id":"NCT02608268","title":"Phase I-Ib/II Study of MBG453 as Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies","status":"TERMINATED","status_verified_date":"2023-12","start_date":"2015-11-23","start_date_type":"ACTUAL","primary_completion_date":"2022-08-30","primary_completion_date_type":"ACTUAL","completion_date":"2022-08-30","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["NVS"]}